Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Bethany A. Nagy"'
Autor:
Dimitris Stellas, Sevasti Karaliota, Vasiliki Stravokefalou, Matthew Angel, Bethany A. Nagy, Katherine C. Goldfarbmuren, Cristina Bergamaschi, Barbara K. Felber, George N. Pavlakis
Publikováno v:
Cell Reports, Vol 42, Iss 5, Pp 112501- (2023)
Summary: Locoregional monotherapy with heterodimeric interleukin (IL)-15 (hetIL-15) in a triple-negative breast cancer (TNBC) orthotopic mouse model resulted in tumor eradication in 40% of treated mice, reduction of metastasis, and induction of immun
Externí odkaz:
https://doaj.org/article/9e387cab5379408199dc1ddc4d8c3d48
Autor:
Vasiliki Stravokefalou, Dimitris Stellas, Sevasti Karaliota, Bethany A. Nagy, Antonio Valentin, Cristina Bergamaschi, Konstantinos Dimas, George N. Pavlakis
Publikováno v:
Frontiers in Immunology, Vol 13 (2023)
Immunotherapy has emerged as a viable approach in cancer therapy, with cytokines being of great interest. Interleukin IL-15 (IL-15), a cytokine that supports cytotoxic immune cells, has been successfully tested as an anti-cancer and anti-metastatic a
Externí odkaz:
https://doaj.org/article/2b9cb05ca9884ddbbe501fcf04cf4111
Autor:
Bernard A Fox, Cristina Bergamaschi, George N Pavlakis, Antonio Valentin, Jenifer Bear, Barbara K Felber, Shawn M Jensen, Hrishikesh Pandit, Bethany A Nagy, Dimitris Stellas, Maggie Cam
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Background Interleukin-15 (IL-15) promotes growth and activation of cytotoxic CD8+ T and natural killer (NK) cells. Bioactive IL-15 is produced in the body as a heterodimeric cytokine, comprising the IL-15 and IL-15 receptor alpha chains (hetIL-15).
Externí odkaz:
https://doaj.org/article/2686c70aeb584a37955fa177f72ca91d
Autor:
George N. Pavlakis, Cristina Bergamaschi, Barbara K. Felber, Bernard A. Fox, Candido Alicea, Xintao Hu, Shawn M. Jensen, Bethany A. Nagy, Sinnie Sin Man Ng
Purpose: Adoptive cell transfer (ACT) is a promising immunotherapeutic approach for cancer. Host lymphodepletion is associated with favorable ACT therapy outcomes, but it may cause detrimental effects in humans. We tested the hypothesis that IL15 adm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43a5e47a5370b59a570b6d9244df9cef
https://doi.org/10.1158/1078-0432.c.6525200
https://doi.org/10.1158/1078-0432.c.6525200
Autor:
George N. Pavlakis, Cristina Bergamaschi, Barbara K. Felber, Bernard A. Fox, Candido Alicea, Xintao Hu, Shawn M. Jensen, Bethany A. Nagy, Sinnie Sin Man Ng
Supplementary Figure 1. IL-15 availability promotes proliferation and maintenance of transferred CD8+ T in the spleen of recipient mice; Supplementary Figure 2. Gating strategy for the identification of adoptively transferred Pmel-1 cells and endogen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fcfc80fca6140c5fd936ffa99addb74
https://doi.org/10.1158/1078-0432.22462775.v1
https://doi.org/10.1158/1078-0432.22462775.v1
Autor:
Saifun Nahar, Yue Huang, Bethany A. Nagy, John A. Zebala, Dean Y. Maeda, Udo Rudloff, Joost J. Oppenheim, De Yang
Publikováno v:
Cancers; Volume 15; Issue 8; Pages: 2366
Triple-negative breast carcinoma (TNBC) is one of the most aggressive types of solid-organ cancers. While immune checkpoint blockade (ICB) therapy has significantly improved outcomes in certain types of solid-organ cancers, patients with immunologica
Autor:
Dimitris Stellas, Sevasti Karaliota, Vasiliki Stravokefalou, Bethany A. Nagy, Barbara K. Felber, George N. Pavlakis
Publikováno v:
Cancer Research. 79:3259-3259
Introduction: IL-15 is a cytokine important for the maintenance, proliferation and activation of lymphocytes, including CD8+ T and natural killer (NK) cells. The native form of IL-15 is a heterodimer either embedded in the plasma membrane or released
Autor:
Nahar, Saifun1,2 (AUTHOR) oppenheij@mail.nih.gov, Huang, Yue1 (AUTHOR), Nagy, Bethany A.1 (AUTHOR), Zebala, John A.3 (AUTHOR), Maeda, Dean Y.3 (AUTHOR), Rudloff, Udo2 (AUTHOR), Oppenheim, Joost J.1 (AUTHOR), Yang, De1 (AUTHOR) yangd@mail.nih.gov
Publikováno v:
Cancers. Apr2023, Vol. 15 Issue 8, p2366. 17p.
Publikováno v:
Cancer Vaccine Week; 3/11/2024, p27-27, 1p
Publikováno v:
Immunotherapy Weekly; 5/16/2023, p875-875, 1p